540729 — Vanta Bioscience Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapMomentum Trap

Annual balance sheet for Vanta Bioscience, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	C2022 March 31st	2023 March 31st	2024 March 31st	R2025 March 31st	2026 March 31st
Period Length:	—	12 M	12 M	12 M	12 M
Source:	Interim Report	ARS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	2.24	0.966	1.61	1.48	1.35
Net Total Accounts Receivable
Net Total Receivables	63.2	73.4	89.2	33.4	59.4
Total Inventory
Total Other Current Assets
Total Current Assets	145	152	172	104	141
Net Property, Plant And Equipment	373	332	284	109	96.8
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	814	847	854	568	661
Accounts Payable
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	143	177	229	196	118
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	574	672	702	397	449
Common Stock
Retained Earnings (Accumulated Deficit)
Total Equity	240	175	152	171	212
Total Liabilities & Shareholders' Equity	814	847	854	568	661
Total Common Shares Outstanding